Enzo Biochem Inc
NYSE:ENZ
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Enzo Biochem Inc
NYSE:ENZ
|
28.3m USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
99.7B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
78.2B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
63.5B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.9B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.9B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.3B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.6B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Enzo Biochem Inc
Glance View
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. The company is headquartered in Farmingdale, New York and currently employs 451 full-time employees. The firm develops, manufactures and sells technology solutions and platforms to clinical laboratories, specialty clinics, researchers and physicians globally. Enzo's segments include Enzo Clinical Lab, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Lab is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. Enzo Life Sciences manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. Enzo Therapeutics is a biopharmaceutical venture that developed multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Enzo Biochem Inc is -0.9%, which is above its 3-year median of -16.3%.
Over the last 3 years, Enzo Biochem Inc’s Net Margin has increased from -55.9% to -0.9%. During this period, it reached a low of -81.7% on Jul 31, 2024 and a high of 65.3% on Jul 31, 2023.
